Form 4: Kratos CEO DeMarco's Equity Transactions
Insider Transaction Report
Kratos Defense & Security Solutions CEO Eric M. DeMarco reported significant equity transactions, including RSU vestings, tax-related share withholdings, and sales under a 10b5-1 plan.
Summary
- CEO Eric M. DeMarco acquired 150,000 shares of common stock through the vesting of Restricted Stock Units (RSUs) on January 3 and 4, 2026.
- A new grant of 150,000 RSUs was made to Mr. DeMarco on January 3, 2026, which will vest ratably over five years.
- 59,120 shares were withheld to cover tax liabilities related to RSU vestings at a price of $79.29 per share.
- Mr. DeMarco sold a total of 200,000 shares of common stock between January 5 and 6, 2026, under a Rule 10b5-1 trading plan adopted on August 29, 2025.
- The sales occurred at weighted average prices ranging from $90.0014 to $91.0212 per share.
- Following these transactions, Mr. DeMarco beneficially owns 749,320 shares of common stock, comprising 687,117 shares held indirectly by a trust and 62,203 shares held directly.
- Direct holdings include 43,674 shares purchased through the Issuer's Employee Stock Purchase Plan and approximately 18,529 shares held through the Issuer's 401(k).
- Additionally, 1,212,500 deferred RSUs have vested but remain subject to a 5-year deferral period, with substantial release scheduled by January 2029.
- An additional 600,000 RSUs are currently unvested and will only vest upon achievement of applicable performance terms described in the company's proxy statement filed on April 4, 2025.
Sentiment
Score: 6
Explanation: The filing is neutral to slightly positive. While there are significant share sales, they are conducted under a pre-arranged 10b5-1 plan, which is a common practice. The continued granting and vesting of RSUs, along with substantial deferred and unvested equity, indicates ongoing executive alignment with long-term company performance.
Positives
- CEO DeMarco received a new grant of 150,000 Restricted Stock Units, indicating continued long-term incentive alignment with company performance.
- The vesting of 150,000 RSUs demonstrates ongoing compensation and retention of key management.
- The existence of 1,212,500 vested but deferred RSUs and 750,000 unvested RSUs (including the new grant) shows significant long-term equity interest by the CEO.
Negatives
- CEO Eric M. DeMarco sold 200,000 shares of common stock, which could be perceived as a reduction in direct equity exposure, although done under a pre-arranged 10b5-1 plan.
- A significant number of shares (59,120) were withheld to satisfy tax liabilities, reducing the net shares received from RSU vestings.
Risks
- The 600,000 unvested RSUs are subject to 'applicable vesting terms described in our proxy statement on Schedule 14A filed with the SEC on April 4, 2025,' implying performance or time-based conditions that may not be met, potentially impacting the CEO's future equity stake.
- The sale of shares by a key executive, even under a 10b5-1 plan, could be interpreted negatively by some investors, potentially signaling a desire for diversification or a lack of confidence, despite the pre-planned nature.
Future Outlook
The CEO has a significant long-term equity interest in the company, with 1,212,500 vested but deferred RSUs scheduled for release by January 2029, and an additional 750,000 unvested RSUs (including the new grant) contingent on future performance. This structure aligns the CEO's incentives with long-term company performance.
Management Comments
- The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request.
Industry Context
This filing reflects routine executive compensation and equity management activities common in the defense and security industry. The use of a 10b5-1 trading plan is a standard practice for executives to sell shares systematically while avoiding accusations of insider trading. The significant RSU grants and deferrals indicate a common strategy to align executive incentives with long-term shareholder value in a sector often characterized by long development cycles and government contracts.
Comparison to Industry Standards
- The structure of executive compensation, involving significant RSU grants with multi-year vesting schedules and deferred compensation, is consistent with practices observed in comparable defense contractors such as Lockheed Martin, Raytheon Technologies, and Northrop Grumman.
- These companies also frequently utilize 10b5-1 plans for executive share sales to manage personal finances while adhering to insider trading regulations.
- The reported share prices for sales are specific to Kratos's market performance and cannot be directly compared to other companies without broader market context.
Stakeholder Impact
- Shareholders: The sale of shares by the CEO could be viewed with caution, but the pre-arranged nature (10b5-1 plan) and continued significant equity holdings (vested deferred and unvested RSUs) suggest ongoing alignment with shareholder interests.
- Employees: The CEO's participation in the Employee Stock Purchase Plan (ESPP) highlights a benefit available to employees and demonstrates alignment with broader employee incentives.
Next Steps
- Continued vesting of the newly granted 150,000 RSUs over the next five years.
- Release of 1,212,500 deferred RSUs by January 2029.
- Vesting of 600,000 performance-based RSUs upon achievement of applicable terms.
Key Dates
| Date | Description |
|---|---|
| 2021-01-04 | Grant date for 150,000 RSUs, vesting ratably over five years. |
| 2022-01-03 | Grant date for 150,000 RSUs, vesting ratably over five years. |
| 2023-01-03 | Grant date for 150,000 RSUs, vesting ratably over five years. |
| 2024-01-04 | Grant date for 150,000 RSUs, vesting ratably over five years. |
| 2025-01-03 | Grant date for 150,000 RSUs, vesting ratably over five years. |
| 2025-04-04 | Date of proxy statement filing (Schedule 14A) detailing vesting terms for 600,000 unvested RSUs. |
| 2025-08-29 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2026-01-03 | Multiple RSU vesting events and a new RSU grant. |
| 2026-01-04 | Multiple RSU vesting events. |
| 2026-01-05 | Sale of 8,301 shares of common stock. |
| 2026-01-06 | Sale of 191,699 shares of common stock and filing date of the Form 4. |
| 2029-01-31 | Approximate date by which substantially all 1,212,500 deferred RSUs are scheduled to be released. |
Recommendation
holdThe filing details routine executive equity transactions, including RSU vestings and sales under a pre-arranged 10b5-1 plan. While the CEO sold a notable number of shares, this is a common practice for diversification and tax planning. The significant remaining equity holdings, including substantial deferred and unvested RSUs, demonstrate continued long-term alignment with the company's performance. There are no new material operational or financial disclosures to warrant a change in investment thesis based solely on this Form 4.
Keywords
Kratos Defense, KTOS, SEC Form 4, Insider Trading, Stock Sales, RSU Vesting, Executive Compensation, Eric M. DeMarco, 10b5-1 Plan, Defense Industry, Security Solutions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.